Connection

Daynna Wolff to Carcinoma, Renal Cell

This is a "connection" page, showing publications Daynna Wolff has written about Carcinoma, Renal Cell.
Connection Strength

1.568
  1. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup. Cancer Genet. 2020 06; 244:40-54.
    View in: PubMed
    Score: 0.700
  2. Clinical utility of concurrent single-nucleotide polymorphism microarray on fresh tissue as a supplementary test in the diagnosis of renal epithelial neoplasms. Am J Clin Pathol. 2015 Nov; 144(5):731-7.
    View in: PubMed
    Score: 0.512
  3. Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls. Acta Neuropathol Commun. 2018 10 19; 6(1):107.
    View in: PubMed
    Score: 0.157
  4. Chromothripsis in Two Patients With Renal Cell Carcinoma: A Case Series. Clin Genitourin Cancer. 2017 02; 15(1):e137-e143.
    View in: PubMed
    Score: 0.134
  5. Abnormal fluorescence in situ hybridization analysis in collecting duct carcinoma. Urology. 2005 Nov; 66(5):1110.
    View in: PubMed
    Score: 0.064
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.